Funda ukuba ingaba i-Arthri-D3 ngokufanelekileyo isebenzisa iArthritis

Inyaniso ehlukileyo kwi-Infomercial Hype

I-Arthri-D3 yongezelelo lokutya eliye lakhuthazwa kakhulu kwi-TV infomercials njengendlela yokususa intlungu ye-arthritis. Zombini kwi-website ye-intanethi ye-Arthri-D3 ethi "ifom ye-revolutionary edibanisa elinye lamabanga aphezulu e-glucosamine kunye nezicatshulwa zezityalo eziphambili."

Izithako ezisebenzayo

Isithako esibalulekileyo kwi-Arthri-D3 yi- N-acetyl-glucosamine (NAG) , uhlobo lwe-glucosamine eveliswa ngokwemvelo emzimbeni.

Ukufumana izongezelelo zokutya ezifana neArthri-D3, ifomu esetyenzisiweyo ivela kwiigobolondo ze-crustacean. Ukongeza kwi-NAG, uluhlu lwezithako ezibandakanya luquka:

Iimpawu zokusetyenziswa

Akukho zibonakaliso ezithile zeArthri-D3 ngaphandle kokukhuthaza impilo ehlangeneyo jikelele. Igama elithi "Arthi" lithetha ukubonisa ukuba uncedo lwe-arthritis, nangona kungekho kuthethwa ngokuthe ngqo kwi-arthritis okanye nayiphi na imeko edibeneyo (njenge- bursitis okanye i- tendinitis ) kwinkampani yokuthengisa.

I-Arthi-D3 ayinakusetyenziswa kubantu abane- shellfish yokungasebenzi .

Iingcebiso zemiba

Ibhotile nganye ye-Arthri-D3 iqulethe iinyanga ezili-120 zokuhambisa iifomsile.

Umvelisi uncoma ukuthatha iipsululwazi ezimbini kusasa kunye neepssile ezimbini kwimini okanye kusihlwa, mhlawumbi ngokutya. Ngenxa yokuba i-Vitamin D i-soluble e-fat, ingcono ixhamle ngokutya.

Umvelisi ukhuthaza kwakhona ukuba uthathe isongezelelo ubuncinane ngeenyanga ezintathu ukuba "uzive uluhlu lwazo olupheleleyo," nangona kungaboniswa ngokucacileyo ukuba zeziphi iingeniso.

Ixabiso leMveliso

Iindleko zenyanga-Arthri-D3 yi-$ 104.99 ngeendleko zokuthunyelwa kunye nokuphatha i-$ 10.49.

Ngokuthelekiswa, iindleko zeephilisi eziyi-120 ze-vitamin D3 ka-2000 IU zi-$ 8.00. Ngokufanayo, i-120-count ye-700-milligram ye-NAG yongezelela i-$ 13.00.

Uphando lwezonyango

Iwebhusayithi ye-Arthri-D3 ayibhalisi naluphi na ubungqina ekusekeleni amabango ayo ngaphandle kokubandakanya ukuhlaziywa okumbalwa kubathengi (amagama okuqala kuphela).

Njengokuxhaswa kokutya, i-Athri-D3 ayifuniyo yi-US Food and Drug Administration ukuba iphinde ibe yinye nqanaba lokuvavanya ngokukhawuleza kuboniswe neziyobisi. Nangona abavelisi abongezelelweyo besondlo bengavumelekanga ukuba bathathe amabango amanga ngeemveliso zabo, i-shishini lonke lilawulwa kakubi kwaye ngokuyininzi lishiywe kwipolisa ngokwayo.

Oku akusiphakamisi ukuba i-glucosamine ayixhaswanga ngokupheleleyo kwizibonelelo zayo kubantu abane-arthritis. Ingxaki kukuba ininzi yezifundo, ezifana nezo zenziwa kwiYunivesithi yaseJuntendo eTokyo ngo-2016 no-2017, zincinci kwaye zifutshane ukuba zithintele naziphi na izigqibo ezingakwazi ukuzenza.

Olunye uphando, olunjengokuphononongwa kweengxelo ezenziwe yiYunivesithi yaseLiege ngo-2012, ziphethwe yintsebenziswano kunye nabenzi bokuvelisa.

Izigqibo

Nangona abaninzi abaphengululi baya kwamkela ukuba i-glucosamine inokunika inzuzo kubantu abanobuhlungu be-arthritis, baya kuqinisekisa ukuba akukho ndlela yokukwazi ukuba yintoni, ukuba kukho nayiphi na impembelelo iya kuba nefuthe lokugula kunye nokuba kutheni inzuzo efunyenwe kwezinye izifundo kwaye kungekhona kwabanye.

Le ngcamango yabelwe yi-American Academy ye-Orthopedic Surgeons yathi: "Akukho bukho bungqina bokuba [glucosamine] uya kuncipha inkqubo yokuguba okanye ukubuyisela i-cartilage kwiindawo ezidlulayo."

> Imithombo:

> I-American Academy ye-Orthopedic Surgeons (AAOS). (2009) "iGlucosamine kunye neCondroitin Sulfate." Iphepha le-AAOS yophando lweKomiti, i-Osteoarthritis kunye ne-Arthritis Foundation. Rosemont, Illinois: AAOS.

> Henrotin, Y .; Mobasheri, A .; kunye noMarty, M. "Ngaba kukho ubungqina benzululwazi bokusetyenziswa kwe-glucosamine ekulawuleni i-osteoarthritis?" Arthritis Res Ther. 2012; 14 (1): 201. INGXELO: 10.1186 / ar3657.

> Kubomura, D .; Ueno, T; Yamada, M. et al. "Impembelelo yolawulo lwe-N-acetylglucosamine kwi-cartilage metabolism kunye nokukhuselwa kwizifundo ezinempilo ngaphandle kweempawu zesifo se-arthritis: ingxelo yengxelo." Exp Ther Med. 2017; 13 (4): 1614-21. INGXELO: 10.3892 / etm.2017.4140.

> Tomonaga, A .; Watanabe, K .; Fukagawa, M. et al. "Ukuphononongwa kwempembelelo ye-N-acetyl-glucosamine ukulawulwa kwezinto ezihamba phambili kwizidumbu ze-cartilage metabolism kubantu abanempilo ngaphandle kwempawu zesifo se-arthritis. Exp Ther Med. 2016; 12 (3): 1481-89. INGXELO: 10.3892 / etm.2016.3480.